<PAGE>1

                           SCHEDULE 14C INFORMATION
                           ------------------------

Information Statement pursuant to Section 14(c) of the Securities Exchange Act
of 1934 (Amendment No.   )

Filed by the Registrant [X]
Filed by a Party other than the Registrant [ ]

Check the appropriate box:

[X] Preliminary Information Statement
[ ] Definitive Information Statement


CYPRESS SEMICONDUCTOR CORPORATION
--------------------------------------------------
(Name of Registrant as specified in its charter)

CYPRESS SEMICONDUCTOR CORPORATION
--------------------------------------------------
(Name of person(s) filing information statement)


Payment of Filing Fee (Check the appropriate box)

[X] $125 per Exchange Act Rules 0-11(c)(1)(ii) or 14(c)-5(g)
[ ] Fee computed on table below per Exchange Act Rules 14(c)-5(g) and 0-11

(1) Title of each class of securities to
          which transaction applies:       COMMON STOCK
                                         -----------------
(2) Aggregate number of securities to which transaction applies:  _____________
(3) Per unit price or other underlying value of transaction computed pursuant
      to Exchange Act Rule 0-11: ____________________(A)
(4) Proposed maximum aggregate value of transaction: _______________________(A)


[ ] Check the box if any part if the fee is offset as provided by Exchange Act
    Rule 0-11(a)(2) and identify the filing for which the offsetting fee was
    paid previously.  Identify the previous filing by registration statement
    number, or the Form or Schedule and the date of its filing.


(1) Amount Previously Paid:  ____________________________
(2) Form, Schedule or Registration Statement No.:  _______________________
(3) Filing Party:  ___________________________
(4) Date Filed:  ___________________________











<PAGE>2
                       CYPRESS SEMICONDUCTOR CORPORATION                       

                            3901 NORTH FIRST STREET
                           SAN JOSE, CALIFORNIA 95134


                             INFORMATION STATEMENT


TO THE STOCKHOLDERS OF CYPRESS SEMICONDUCTOR CORPORATION:

     NOTICE IS HEREBY GIVEN that the Board of Directors of Cypress
Semiconductor Corporation, a Delaware corporation (the "Company"), has
unanimously approved an amendment of the Company's Certificate of Incorporation
to increase the authorized number of shares of Common Stock of the Company
from 75,000,000 shares to 250,000,000 shares (the "Amendment").  If approved by
the Company's stockholders, the Amendment will enable the Company to effect a
two-for-one split of the Company's outstanding shares of Common Stock (the
"Stock Split") structured as a stock dividend.  In order for such amendment to
become effective, such amendment must be approved by holders of a majority of
the Company's outstanding shares of Common Stock.  The purpose of this
Information Statement is to solicit such stockholder approval by written
consent.

     Only stockholders of record at the close of business on September 29, 1995
are entitled to notice of the proposed action and to provide or withhold their
written consent to such action.  The amendment of the Company's Certificate of
Incorporation will be filed with the Secretary of State of Delaware on or about
October 23, 1995 if approved by the holders of a majority of the Company's
outstanding shares of Common Stock through their written consent received prior
to such time.  The Company's Transfer Agent will begin distribution of the stock
certificates representing the dividend effecting the Stock Split on or about
October 31, 1995.

                                 By Order of the Board of Directors


                                 Emmanuel Hernandez
                                 Secretary


San Jose, California
September 29, 1995









YOUR CONSENT IS IMPORTANT.  PLEASE COMPLETE, SIGN AND RETURN THE ACCOMPANYING
WRITTEN CONSENT OF STOCKHOLDERS NO LATER THAN OCTOBER 18, 1995.

THE FORM OF CONSENT TO BE COMPLETED DOES NOT CONSTITUTE A PROXY.  WE ARE NOT
ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND US A PROXY.



<PAGE>3

                             INFORMATION STATEMENT                              
                                      OF
                       CYPRESS SEMICONDUCTOR CORPORATION

                            3901 NORTH FIRST STREET
                           SAN JOSE, CALIFORNIA 95134

                         INFORMATION CONCERNING VOTING


     This Information Statement and the accompanying written consent of
stockholders (the "Written Consent") are being furnished to the stockholders of
Cypress Semiconductor Corporation (the "Company") in connection with a proposal
by the Company's Board of Directors to (i) amend the Company's Certificate of
Incorporation to increase the authorized number of shares of Common Stock of
the Company from 75,000,000 shares to 250,000,000 shares and (ii) effect a
two-for-one split of the Company's outstanding shares of Common Stock
structured as a 100% stock dividend.  The Written Consent is solicited by the
Board of Directors of the Company and provides that a stockholder who marks,
signs and mails the Written Consent as directed will be counted and consenting
to (or withholding consent to) the Amendment if such Written Consent is
received by the Company before the close of business on October 18, 1995.

PROCEDURAL MATTERS

     These materials are being mailed on or about September 29, 1995 to holders
of record of the Company's Common Stock on such date.  Only stockholders of
record on September 29, 1995 (the "Record Date") are entitled to a notice of and
to consent or withhold consent to the Amendment.  As of September 22, 1995
______________ shares of Common Stock, par value $0.01 per share (the "Common
Stock"), were outstanding.

     Before the Amendment can become effective, holders of a majority of the
Company's outstanding Common Stock must provide their written consent.
Stockholders wishing to consent (or to withhold consent) to the Amendment are
asked to sign and return the Written Consent by October 18, 1995.  Each
stockholder is entitled to one vote for each share of Common Stock held on the
record date for purposes of the Written Consent.  Any consent may be revoked in
writing at any time, provided such written revocation is received by the
Secretary of the Company prior to the close of business on October 13, 1995.
If holders of a majority of the Company's outstanding shares of Common Stock
provide consent, the Amendment is expected to become effective on or about
October 23, 1995, upon the filing of the Amendment with the Secretary of State
of Delaware.

COST OF SOLICITING CONSENTS

     The cost of soliciting consents in the accompanying form has been, or will
be, borne by the Company.  The Company has retained Corporate Investor
Communications, Inc. to assist in the solicitation of proxies at an estimated
fee of [$5,500] plus reimbursement of reasonable expenses.  In addition to
solicitation by mail, the Company requests banks, brokers and other custodians,
nominees and fiduciaries to send Information Statements to the beneficial
owners and to secure their instructions as to consents.  The Company will
reimburse them for their reasonable solicitation expenses.




<PAGE>4

         PROPOSAL TO AMEND THE COMPANY'S CERTIFICATE OF INCORPORATION        
    TO INCREASE SHARES OF AUTHORIZED COMMON STOCK AND TO APPROVE STOCK SPLIT

     In August, 1995, the Board of Directors of the Company (the "Board")
unanimously adopted a resolution approving an amendment of the Company's
Certificate of Incorporation to (i) increase the authorized number of shares
of Common Stock of the Company from 75,000,000 shares to 250,000,000 shares and
(ii) effect a two-for-one split of the Company's outstanding shares of Common
Stock.  Each additional share of Common Stock authorized by the Amendment will
have the same rights and privileges as each share of Common Stock currently
authorized or outstanding.

     The objectives of the Stock Split are to lower the market price of the
Company's Common Stock and to increase its trading activity, each of which is
expected to increase the liquidity and broaden the marketability of the Common
Stock.
 
     If the Amendment is approved by the stockholders, each record holder of
the Company's Common Stock as of October 19, 1995 will be entitled to receive
one additional share of Common Stock for each share of Common Stock held on
such date.  Thus, if the Amendment is authorized and the Stock Split occurs,
the Company's stockholders will hold twice the number of shares of Common Stock
held before the Stock Split, but each stockholder's proportionate equity
interest in the Company will not change.  In addition, the number of shares of
Common Stock subject to options granted pursuant to the Company's 1994 Stock
Option Plan and the Employee Stock Purchase Plan (collectively, the "Plans"),
and the number of shares of Common Stock reserved for issuance under the Plans
will be doubled, the exercise price of outstanding options will be divided by
two and the conversion rate of the Company's outstanding convertible debentures
will be similarly adjusted.

     Prior to effectiveness of the Amendment, the Company has 75,000,000
authorized shares of Common Stock.  The Company is proposing to increase its
reserve of authorized but unissued shares in order to avoid the time and
expense of seeking shareholder approval in the future each time it needs to
make a new issuance of Common Stock, whether in connection with an acquisition,
an increase in shares reserved under an employee stock or option plan, an
equity offering, a stock dividend or some other time-sensitive situation.  In
order to maintain a reserve equivalent to that which existed prior to the stock
split, 75,000,000 shares would be required to be added to those currently
authorized to bring the total authorized to 150,000,000.  Based upon the
proposal set forth herein, following the effectiveness of the Amendment and the
Stock Split, the Company will increase the reserve to 250,000,000 authorized
shares available pursuant to its Certificate of Incorporation.  While
the Company has no specific, present intentions for the use of such shares, the
Company believes that maintaining such a reserve could save time and money in
responding to future events requiring the issuance of additional shares of
Common Stock, such as acquisitions, equity offerings or increases in the number
of shares reserved under employee stock and options plans.  Moreover, such
shares may be used in connection with future stock splits effected by means of
the issuance of a stock dividend, if the Board of Directors concludes that it
is in the interest of the Company's stockholders to implement any such stock
dividends in the future.  The additional shares of Common Stock authorized but
not required to effect the Stock Split would be available for issuance from
time to time by the Board of Directors without future stockholder action.




<PAGE>5

REQUIREMENT FOR STOCKHOLDER APPROVAL

     A majority of the shares of Common Stock issued and outstanding as of the
Record Date is required to approve the proposed amendment of the Certificate of
Incorporation, as described above.  Upon receipt of such majority approval, the
Amendment is expected to become effective on or about October 23, 1995, upon
the filing of the amendment with the Secretary of State of Delaware.



     THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT THE STOCKHOLDERS
APPROVE THE PROPOSED AMENDMENT OF THE COMPANY'S CERTIFICATE OF INCORPORATION.











































                                      -2-



<PAGE>6

                             ADDITIONAL INFORMATION                             

                          DESCRIPTION OF CAPITAL STOCK


     The Company has authorized an aggregate of 75,000,000 shares of Common
Stock and 5,000,000 shares of Preferred Stock.  As of September 22, 1995, there
were _____________ shares of Common Stock outstanding, held of record by 
approximately ________ shareholders.  There are no shares of Preferred Stock
outstanding.

COMMON STOCK

     The holders of Common Stock are entitled to one vote per share on all
matters to be voted upon by the stockholders.  Subject to any dividend
preferences of the Preferred Stock, if any, then outstanding, the holders of
Common Stock are entitled to receive ratably such dividends, if any, as may be
declared from time to time by the Board of Directors out of funds legally
available therefor. In the event of a liquidation, dissolution or winding up of
the Company, the holders of Common Stock are entitled to share ratably in all
assets remaining after payment of liabilities, subject to any prior liquidation
rights of Preferred Stock, if any were then outstanding.  The Common Stock has
no preemptive or conversion rights or other subscription rights.  There are no
redemption or sinking fund provisions applicable to the Common Stock.


PREFERRED STOCK

     The Board of Directors has the authority, without further stockholder
approval, to issue the undesignated Preferred Stock from time to time in one or
more series and to establish the number of shares to be included in each such
series, and to fix or alter the voting powers and the designation, preferences
and relative participating, optional or other special rights and
qualifications, limitations or restrictions of such series of Preferred Stock,
or any or all of them.  Any future issuance of Preferred Stock may have the
effect of delaying or preventing a change in control of the Company without
further action by the stockholders.  The issuance of Preferred Stock with
voting and conversion rights may adversely affect the voting power of the
holders of Common Stock, including the loss of voting control to others.  The
Company currently has no plans to issue shares of Preferred Stock.


CONVERTIBLE DEBENTURES:

     The Company currently has outstanding $110 million in subordinated notes
convertible into 3,969,600 shares of Common Stock.  The conversion ratio of such
notes will be adjusted in accordance with the Stock Split to increase by a
multiple of two the number of shares reserved for issuance upon conversion of
the notes.






                                      -3-



<PAGE>7

        SECURITIES OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT       

     The following tables set forth, as of August 31, 1995, information
relating to the ownership of the Company's Common Stock beneficially owned by
(i) each person known to the Company to be the beneficial owner of more than 5%
of the Company's voting stock, (ii) each director, (iii) each person who was an
executive officer at the end of the last completed fiscal year and (iv) all
executive officers and directors as a group.  Except as indicated in the
footnotes to this table, the persons named in the table have sole voting and
investment power with respect to all shares shown as beneficially owned by
them, subject to community property laws where applicable.

                                                   SHARES BENEFICIALLY OWNED
                                                 ----------------------------- 
   DIRECTORS, OFFICERS, AND 5% STOCKHOLDERS          NUMBER        PERCENT
-----------------------------------------------  -------------- --------------
PRINCIPAL STOCKHOLDERS (1)
--------------------------
 FMR Corp. (2)                                        5,005,151          12.0%
   82 Devonshire Street
   Boston, Massachusetts 02109
 
 Merrill Lynch & Co., Inc. (3)                        3,203,101           7.7%
   World Financial Center, North Tower
   250 Vesey Street
   New York, New York  10281

 AIM Management Group, Inc. (4)                       2,192,200           5.2%
   11 Greenway Plaza,  Suite 1919
   Houston, Texas  77046

DIRECTORS
--------------------------
 T.R. Rodgers (5)                                       701,915           1.7%

 Pierre R. Lamond (6)                                    99,668            *
 
 Fred B. Bialek (7)                                     160,709            *

 Eric A. Benhamou (8)                                    20,000            *

 John C. Lewis (9)                                       23,333            *

NAMED OFFICERS
--------------------------
 J. Daniel McCranie (10)                                  4,725            *

 Antonio Alvarez (11)                                    23,402            *

 Emmanuel Hernandez (12)                                 17,458            *

 Lothar Maier (13)                                       13,971            *

 All directors and executive officers at fiscal       1,065,181           2.5%
  year end as a group (9 persons) (14)           

                                      -4-


<PAGE>8

-----------------
* less than 1%

 (1) Based on filings (as of 12/31/94) pursuant to Section 13(g) of the
     Securities Exchange Act of 1934, as amended.

 (2) FMR Corp., through its control of two wholly owned subsidiaries, Fidelity
     Management and Research Company and Fidelity Management Trust Company, has
     sole dispositive power with respect to an aggregate of 5,005,151 shares. 
     Edward C. Johnson 3d., Chairman of FMR Corp., and various other Johnson
     family members and trusts for the benefit of Johnson family members
     together form a controlling group with respect to FMR Corp.

 (3) Merrill Lynch & Co., Inc., shares voting and dispositive power with
     respect to 3,203,101 shares with Merrill Lynch Group, Inc., Princeton
     Services, Inc., Merrill Lynch Asset Management, L.P. and Merrill Lynch
     Growth Fund for Investment and Retirement.

 (4) AIM Management Group Inc., shares voting and dispositive power with
     respect to 2,192,200 shares with its wholly owned subsidiaries, AIM
     Advisors, Inc. and AIM Capital Management, Inc.

 (5) Mr. Rodgers is also President and Chief Executive Officer of the Company. 
     Includes options to purchase 497,016 shares of Common Stock exercisable
     within 60 days of August 31, 1995.

 (6) Includes 61,268 shares held by the Lamond Living Trust.  Also includes
     options held by Mr. Lamond to purchase 11,041 shares of Common Stock
     exercisable within 60 days of August 31, 1995.

 (7) Represents options to purchase 160,709 shares of Common Stock exercisable
     within 60 days of August 31, 1995.

 (8) Represents options to purchase 20,000 shares of Common Stock exercisable
     within 60 days of August 31, 1995.

 (9) Represents options to purchase 23,333 shares of Common Stock exercisable
     within 60 days of August 31, 1995.

(10) Represents options to purchase 4,725 shares of Common Stock exercisable
     within 60 days of August 31, 1995.

(11) Represents options to purchase 23,402 shares of Common Stock exercisable
     within 60 days of August 31, 1995.

(12) Represents options to purchase 17,458 shares of Common Stock exercisable
     within 60 days of August 31, 1995.

(13) Includes options to purchase 11,161 shares of Common Stock exercisable
     within 60 days of August 31, 1995.

(14) Includes options held by officers and directors of the Company to purchase
     an aggregate of 768,845 shares of Common Stock exercisable within 60
     days of August 31, 1995.


                                      -5-


<PAGE>9

    (Front side of Written Consent Card)



                       CYPRESS SEMICONDUCTOR CORPORATION

                        WRITTEN CONSENT OF STOCKHOLDERS
                              IN LIEU OF A MEETING

                 THIS WRITTEN CONSENT IS SOLICITED ON BEHALF OF
                             THE BOARD OF DIRECTORS


     The undersigned stockholders of CYPRESS SEMICONDUCTOR CORPORATION, a
Delaware Corporation (the "Company"), in accordance with Section 228 of the
Delaware General Corporation Law and the bylaws of the Company, take the
following action by Written Consent in lieu of a meeting:





     

                    CONTINUE AND TO BE SIGNED ON REVERSE SIDE


































<PAGE>10


     (Backside of Written Consent Card)




     [X]  Please mark votes as in this example


     RESOLVED: That the stockholders of the Company hereby approve an amendment
               of the Certificate of Incorporation to effect an increase in the
               authorized number of shares of Common Stock of the Company from
               75,000,000 to 250,000,000 shares.

This Written Consent is effective as of the date indicated below.

     THIS IS AN ACTION BY WRITTEN CONSENT.  THIS IS NOT A PROXY.  THE SHARES
REPRESENTED BY THIS WRITTEN CONSENT WILL BE VOTED IN ACCORDANCE WITH THE
SPECIFICATION MADE HEREIN.  IF YOU WISH TO AUTHORIZE THE RESOLUTION ABOVE, MARK
THE BOX BELOW LABELED "CONSENT GRANTED".  IF YOU WISH NOT TO AUTHORIZE THE
RESOLUTION, MARK THE BOX LABELED "CONSENT WITHHELD".  PLEASE MARK, SIGN, DATE
AND RETURN THIS WRITTEN CONSENT PROMPTLY USING THE ENCLOSED ENVELOPE.

       
               Consent                         Consent
               Granted                         Withheld

                [  ]                             [  ]





Note:  Please sign exactly as name appears on your stock certificate.  If the
       stock is registered in the names of two or more persons, each should
       sign.  Executors, administrators, trustees, guardians, attorneys and
       corporate officers should insert their titles. 


Signature:   ____________________________________   Date:  _________________

Signature:   ____________________________________   Date:  _________________